@article{Joy_M-2023_144295,
title = {Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort},
author = {Joy, M. and Agrawal, U. and Fan, X. and Robertson, C. and Anand, S. and Ordóñez-Mena, J. and Byford, R. and Goudie, R. and Jamie, G. and Kar, D. and Williams, J. and Marsden, G. and Tzortziou-Brown, V. and Sheikh, A. and Hobbs, F. and de Lusignan, S.},
month = {jul},
year = {2023},
abstract = {BackgroundThrombosis associated with thrombocytopenia was a matter of concern post first and second doses of BNT162b2 and ChAdOx1 COVID-19 vaccines. Therefore, it is important to investigate the risk of thrombocytopenic,thromboembolicand haemorrhagic events following a second dose of BNT162b2 and ChAdOx1 COVID-19 vaccines.},
volume = {32},
journal = {The Lancet Regional Health - Europe},
publisher = {Elsevier},
url = {https://doi.org/10.1016/j.lanepe.2023.100681},
}
